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INTRODUCTION 
 
 
        Hypertension and tachycardia occurring during laryngoscopy and 
endotracheal intubation in a light plane of anaesthesia has been reported 
since 1950 24. This increase in blood pressure and heart rate occurs most 
commonly from reflex sympathetic discharge in response to laryngotracheal 
stimulation, which in turn causes increased plasma norepinephrine 
concentration 16.The response following laryngoscopy and intubation peaks 
at 1.2 minutes and returns to baseline within 5 to 10 minutes.Though these 
sympathoadrenal responses are probably of little consequence in healthy 
individuals, it is hazardous to those with hypertension, coronary artery heart 
disease, intracranial pathology and hyperactive airways. In such cases, these 
responses need to be suppressed. 
 
            Tachycardia, hypertension and dysrhythmias all occur during 
laryngoscopy and intubation 29. The consequent increase in Rate Pressure 
Product may result in a myocardial oxygen demand which exceeds the 
myocardial oxygen supply resulting in myocardial ischaemia. This response 
is sympathetically mediated. Prof King et al 24 documented myocardial 
ischaemic changes due to reflex sympathoadrenal response immediately 
following laryngoscopy and intubation with a mean increase in systemic 
pressure of 40 mm Hg even in normotensive patients. 
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                  An increase in heart rate is more likely to produce signs of 
myocardial ischaemia on the ECG than hypertension. Indeed, in 
anaesthetized patients, the incidence of myocardial ischaemia on the ECG 
increases in patients who experience a heart rate greater than 110 beats per 
minute (Ischaemic Threshold). A frequent recommendation is to maintain 
the heart rate and blood pressure within 20% of the normal awake value for 
that patient. 
 
                  Many attempts have been made to attenuate the pressor response 
to laryngoscopy and intubation. They are:      
         
1. Intubating in a deep plane of anaesthesia 35              
2. Use of topical anaesthesia 23,50 
3. Use of  ganglionic blockers 44 
4. Use of intravenous local anaesthetics 50 
5. Use of arterial dilators – hydrallazine, SNP 49 
6. Use of venodilators – NTG 15 
7. Use of magnesium sulphate 
8. Use of betablockers – Esmolol 12 
9. Ca channel blockers 36 
10. Use of opioids – Fentanyl, Morphine, Pethidine 1,2,3     
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          All the methods detailed above have their own advantages and 
disadvantages. High dose opioids have been used to attenuate circulatory 
responses to laryngoscopy and intubation more commonly and is supported 
by many studies. But high dose opioids have shortcomings like:   
 
1)  Producing undue sedation thereby becoming unsuitable for short 
procedures. 
2)    troublesome respiratory depression thereby delaying recovery; and may   
even require postoperative ventilatory support. 
3)     adverse effects like severe nausea and vomiting occurs more frequently 
with   high doses.  
 
           To overcome these disadvantages, small dose opioids, especially 
Fentanyl is increasingly being used to effectively attenuate the stress 
response during anaesthetic induction. However, there have been only a few 
studies to evaluate the optimal time for injection of small dose Fentanyl to 
effectively obtund the secondary circulatory responses to laryngoscopy and 
endotracheal intubation. 
 
          Hence this study was designed to evaluate the optimal time for 
injecting small dose Fentanyl preoperatively, to effectively attenuate the 
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circulatory responses accompanying laryngoscopy and intubation during 
anaesthetic induction.    
                  After getting approval from the hospital ethical committee, I 
carried out this study in the Department of Anaesthesiology, Madras 
Medical College and Government General Hospital, Chennai, during the 
period from November 2005 to February 2006.  
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AIM OF STUDY 
 
 
 
           To evaluate the optimal time for injecting small dose Fentanyl (2 µg / 
kg body wt) preoperatively to attenuate the circulatory responses to 
laryngoscopy and endotracheal intubation during anaesthetic induction.  
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ANATOMY – NERVE SUPPLY OF LARYNX 
 
 
 
              Nerve supply to the larynx is from the Superior laryngeal nerve and 
the Recurrent laryngeal nerve, both of which are branches of the vagus 
nerve. 
 
             The Superior laryngeal nerve arises from the middle of the inferior 
ganglion of the vagus, runs downwards and forwards on the superior 
constrictor muscle deep to internal carotid artery and reaches the middle 
constrictor muscle, where it divides into external laryngeal nerve and 
internal laryngeal nerve. External laryngeal nerve is thin, accompanies the 
superior thyroid artery, pierces the deep constrictor and ends by supplying 
the cricothyroid muscle.  
 
              Right recurrent laryngeal nerve arises from the vagus in front of the 
right subclavian artery, winds backwards below the artery to reach the 
tracheo-oesophageal groove. It is related to the inferior thyroid artery in its 
upper part. The nerve then passes deep to lower border of inferior constrictor 
muscle, and enters the larynx behind the cricothyroid joint. It supplies all the 
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intrinsic muscles of the larynx except the cricothyroid and carries sensory 
fibres to the larynx below the level of vocal cords.      
                  The left recurrent laryngeal nerve arises from the vagus in the 
thorax. It curves around the aortic arch and soon gains entry into the tracheo- 
oesophageal groove. Thereafter its course is similar to that of the right 
recurrent laryngeal nerve.        
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PHYSIOLOGIC AND PATHOLOGIC RESPONSES TO 
DIRECT LARYNGOSCOPY AND ENDOTRACHEAL 
INTUBATION 
 
 
                   Intubation of the trachea alters respiratory and cardiovascular 
physiology by both reflex response and by the physical presence of an 
endotracheal tube. Although the reflex responses are generally of short 
duration and of little consequence in the majority of patients, they may 
produce profound disturbances in patients with underlying abnormalities 
such as hypertension, coronary artery heart disease, reactive airways and 
intracranial pathology.  
 
                 The cardiovascular responses to laryngoscopy and intubation are 
bradycardia, tachycardia and hypertension; and they are mediated by both 
the sympathetic and parasympathetic nervous systems. Bradycardia is often 
seen in infants and small children during laryngoscopy and intubation. 
Although only rarely seen in adults, this reflex is mediated by an increase in 
vagal tone at the sinoatrial node and is virtually a monosynaptic response to 
a noxious stimulus in the airway.  
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                 The more common response to endotracheal intubation is 
hypertension and tachycardia mediated by sympathetic efferents via the 
cardioaccelerator nerves and sympathetic chain ganglia. The polysynaptic 
nature of pathways from the IX and X nerve afferents to the sympathetic 
nervous system via the brainstem and spinal cord results in a diffuse 
autonomic response which includes widespread release of norepinephrine 
from adrenergic nerve terminals and adrenal medulla.     
                   
                 Some of the hypertensive response to endotracheal intubation also 
results from activation of the Renin-Angiotensin system, with release of 
renin from the renal juxtaglomerular apparatus and endorgan innervated by 
beta adrenergic nerve terminals. The effects of endotracheal intubation on 
the pulmonary vasculature are probably less well understood than the 
responses elicited in the systemic circulation. They are often coupled with 
changes in airway reactivity associated with intubation. These are: 
 
 
1) glottic closure reflex, i.e. laryngospasm due to brisk motor       
response 
2) reduction in dead space 
 
3) increase in airway resistance 
 
4) bronchospasm as a reflex response to intubation 
 
5) removal of the glottic barrier and may lower lung volume 
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6) cough efficiency is reduced  
 
 
METHODS TO ATTENUATE CIRCULATORY 
RESPONSES DURING LARYNGOSCOPY AND 
ENDOTRACHEAL INTUBATION 
 
 
 
         
          The balance of myocardial oxygen supply and demand must be 
preserved to minimize the risk of perioperative ischaemia and infarction. 
Factors affecting myocardial oxygen supply are: 
 
 1)   Heart rate                
Supply depends upon diastolic time. Hence, lower the heart rate, 
more the diastolic time and more the oxygen supply to myocardium. 
 
2) Coronary perfusion pressure 
Depends on aortic diastolic pressure and ventricular end diastolic 
pressure and it increases with a high aortic diastolic pressure and low 
ventricular end diastolic pressure. 
 
3) Arterial oxygen content 
Depends on arterial oxygen tension and hemoglobin concentration. 
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4) Coronary vessel diameter  
               Supply is directly proportional to diameter of coronary vessel. 
Hence when the vessel is stenosed, the supply is reduced. 
Factors affecting myocardial oxygen demand are 
 
1) Basal requirement 
2) Heart rate 
3) Wall tension – Preload and afterload 
4) Contractility 
 
                  A number of methods were used to attenuate cardiovascular 
response due to laryngoscopy and endotracheal intubation. They are: 
 
1) Deepening the plane of General Anaesthesia 
            The dose of volatile inhalational agents required to block the 
responses to endotracheal intubation is termed as MAC – ei. This deep level 
of anaesthesia achieved by inhalational agents results in profound 
cardiovascular depression prior to endotracheal intubation.The various agents 
that are used to obtund the intubation responses are Halothane, Isoflurane and 
Sevoflurane. 
 
2) Lidocaine 
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            The various modes by which lidocaine is used to attenuate the 
responses to direct laryngoscopy and endotracheal intubation are: 
     i)  Lidocaine gargles for oropharyngeal anaesthesia 
    ii)  Aerosol for intratracheal anaesthesia 
   iii)  Topical spray over the cords 
   iv)   Regional nerve blocks 
a) Superior Laryngeal Nerve 
b) Glossopharyngeal nerve    
  v)   Intravenous bolus for systemic anaesthesia  
   Topical anaesthesia of the upper airway has proven to be less effective 
than systemic administration of lidocaine.  
 
Mechanism of action of lidocaine  
1) By increasing the depth of anaesthesia 
2) Potentiation of the effects of N2O anaesthesia and reduction 
of MAC of Halothane by 10 to 28 % 
3) Direct cardiac depression 
4) Peripheral vasodilatation 
5) Antiarrythmic properties 
6) Suppression of cough reflex  
 
3) Vasodilators 
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1. Hydralazine 
2. Sodium Nitroprusside 
3. Nitroglycerine 
 
4) Narcotics   
1. Fentanyl 
2. Alfentanyl  
3. Sufentanil 
4. Remifentanyl 
5. Morphine 
6. Pethidine 
 
     Of these, Fentanyl is the most commonly used narcotic agent to 
attenuate the    responses to intubation. 
 
Mechanism of action 
a) suppresses the nociceptive stimulation caused by 
intubation. 
b) centrally mediated decrease in sympathetic tone ( Lambie 
et al 1974).  
c) Activation of vagal tone. 
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5) Adrenergic Blockers  
             α  receptor blockers: Phentolamine 
             β  receptor blockers: Esmolol, Metaprolol, Propranol 
           α and β receptor blockers: Labetalol   
 
            Of these, Esmolol is the most commonly used agent because of 
its ultrashort duration of action.It reduces resting heart rate, systolic 
blood pressure, rate pressure product, ejection fraction and cardiac index; 
but it maintains the coronary perfusion pressure.  
 
6) Calcium Channel Blockers   
           Nifedipine, Nicardipine, Diltiazem, Verapamil 
          Of these, Diltiazem is the most commonly used drug though 
Nicardipine has superior actions. 
 
7) α2  agonist 
Clonidine – it acts by suppressing the increase in sympathetic 
activity produced by laryngoscopy and intubation. 
 
8)   Midazolam:  Sedative and anxiolytic 
 
9)   Magnesium Sulphate:   Sedative and anxiolytic               
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PHARMACOLOGY OF FENTANYL 
 
                  Fentanyl, the first of the present generation of potent aniline-
piperidine opioids, as introduced into clinical practice in the mid-1960s. It 
was shown to be 80 – 100 times as potent as morphine, with a high 
therapeutic index, shorter duration of action, more specific, and with fewer 
adverse effects than morphine. Fentanyl is a synthetic opioid which acts at 
the µ receptors as an agonist.                                    
                                 
                                                                               
PHARMACODYNAMICS    
              
 
I) ACUTE EFFECTS 
 
      
1) CENTRAL NERVOUS SYSTEM EFFECTS 
 
               a)   Analgesia 
 
               b)   Sedation 
 
      c)   Euphoria 
 
      d)   Respiratory depression 
 
      e)   Cough suppressant 
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      f)   Miosis 
 
      g)   Nausea and vomiting 
 
      h)  Skeletal muscle rigidity 
 
 
2) CARDIOVASCULAR EFFECTS 
 
a) Bradycardia – central vagal stimulation in high doses 
 
b) No effect on cardiac contractility 
 
c) Hypotension , especially in large doses due to bradycardia,      
venodilatation and suppression of central sympathetic outflow 
 
3) RESPIRATORY SYSTEM EFFECTS 
 
Dose dependent respiratory depression through direct action 
 
 
a) Apnoic threshold increased 
 
b) Hypoxic drive decreased 
 
c) Chest wall rigidity causes decrease in lung compliance 
 
d) Delayed respiratory depression   
 
              
4)  GASTROINTESTINAL TRACT EFFECTS  
 
 
               a)   Delays gastric emptying 
 
b) Causes biliary colic  
 
    
5) ENDOCRINE SYSTEM EFFECTS 
 
a) Attenuation of stress response 
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6)   MISCELLANEOUS 
 
b) Histamine release 
 
c) Smooth muscle spasm 
 
 
II)   CHRONIC EFFECTS 
a) Tolerance 
b) Physical dependence 
 
                              
MECHANISM OF ACTIONS 
 
 
 1)  ANALGESIA AND MOOD EFFECTS 
 
a) The processing of pain information is inhibited by a direct spinal 
effect on the dorsal horn of spinal cord. 
b) Rostral transmission of pain signals is decreased by activation of       
descending inhibitory pathways in the brainstem. 
c) Emotional response to pain is altered by opioid actions on the 
limbic cortex.   
d) Act at receptors located peripherally on the sensory neurons. 
 
 
 
2) RESPIRATORY DEPRESSION 
 
               Direct effect on respiratory centers in the medulla. 
 
 
3) ANTITUSSIVE 
 
               Direct effect on cough centers in the medulla. 
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4) MIOSIS 
 
               Stimulation  of  the  Edinger – Westphal  nucleus  of  the  oculomotor  
 
 nerve. 
 
5) NAUSEA AND VOMITING 
 
  Stimulation  of  Chemoreceptor  Trigger  Zone  complex  interaction of 
dopaminergic, cholinergic or serotonergic mechanisms. 
 
6) MUSCLE RIGIDITY 
 
              By acting at the receptors in the striatum, it increases the rate of 
striatal dopamine biosynthesis and inhibits the release of the 
inhibitory neurotransmitter Gamma Amino Butyric Acid (GABA). 
 
7) CARDIOVASCULAR SYSTEM 
 
a) Bradycardia – stimulation of central vagal nuclei 
b) Peripheral vasodilatation – depression of vasomotor  centre  in the 
medulla 
c) Decreased central sympathetic tone – raising the arrhythmogenic 
threshold 
d)  Hypotension – especially  in  patients  with  elevated sympathetic   
tone due to hypovolumia and cardiac failure. 
 
8) TOLERANCE 
a) Acute tolerance or tachyphylaxis 
b) Chronic tolerance 
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c) Cross tolerance to other opioid agonists  
               Tolerance develops most rapidly to the depressant effects of opioids. 
 
PHARMACOKINETICS 
 
               Fentanyl is a potent synthetic opioid, which is extremely fat soluble 
and has a rapid onset and a relatively short duration of action. After 
intravenous administration, it is rapidly distributed to the brain, heart and 
other highly perfused areas. It readily crosses the blood brain barrier and the 
placental barrier. Peak effect occurs in 3 – 5 minutes. Within a short time, the 
drug distributes extensively throughout the body so that the plasma level falls 
precipitously. This large concentration gradient thus produced favours the 
redistribution of Fentanyl away from the central nervous system and thus 
terminates its effect. When redistribution is almost completed, the elimination 
phase begins so that the plasma levels fall much more slowly.   
METABOLISM 
 
               Fentanyl is biotransformed in the liver to inactive metabolites, 
primarily to Norfentanyl and several hydroxylation products. Only 6 to 8 % of 
the drug is excreted unchanged in the urine. The hepatic clearance of the drug 
is high (12 to 13 µg / kg body wt / minute). When given orally, the first pass 
metabolism is nearly 60%. The large volume of distribution however means 
that the drug remains extravascular and hence available for biotransformation. 
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The long elimination half life of Fentanyl (3 – 4 hrs) is a function of the slow 
rate at which the drug reenters the central compartment. Fentanyl concentration 
in plasma correlates well with cerebrospinal fluid concentration and 
pharmacodynamic effects. Fentanyl pharmacokinetics therefore predicts some 
of the most important pharmacodynamic properties. When low doses (1 – 3 µg 
/ kg body wt) of Fentanyl are administered, redistribution terminates the effect 
and hence the drug appears short acting. In large doses (> 20 µg / kg body wt), 
redistribution is not sufficient to terminate the effect and so it depends on the 
elimination process which is slow and hence the drug appears long acting. 
Repeated intravenous boluses are likely to cause cumulative effects. High 
hepatic extraction ratio (0.6%) means that the clearance is limited by hepatic 
blood flow. 
ROUTES OF ADMINISTRATION 
 
                Due to high first pass metabolism by the liver, oral route is 
inefficient. The most reliable route is intravenous. The drug is also well 
absorbed transdermally, intranasally and by the oral mucosa. 
 
ADVERSE EFFECTS 
a) Respiratory depression 
b) Apnoea 
c) Muscular rigidity 
 27
d) Bradycardia 
e) Hypotension 
f) Dizziness 
g) Blurred vision 
h) Nausea and vomiting 
i) Laryngospasm 
j) Diaphoresis 
 
DOSAGE AND ADMINISTRATION 
 
              Dosages should be individualized. Some of the factors that should be 
considered while determining the dose are age, bodyweight, physical status, 
underlying pathological condition, use of other drugs, type of anaesthesia to be 
used and the surgical procedures involved. One problem with Fentanyl was the 
wide inter-individual variability, as typified in the paper of Reilly and 
colleagues 2, who described a wide range of variability in disposition within 
seven different sets of parameters. The different dosage schedules commonly 
followed are: 
 
1) PREMEDICATION 
             50 – 100 µg may be administered intramuscularly 30 to 60 minutes 
before surgery. 
 28
2) ADJUNCT TO GENERAL ANAESTHESIA 
 
             In the 1990s, the optimal strategy for dosing with Fentanyl is probably 
that of “Balanced Anaesthesia”, where Fentanyl is supplemented by Isoflurane 
or another volatile agent. To provide analgesia, plasma drug concentrations 
need to be around 1-2 ng / ml; this can best be achieved using a loading dose of 
2-8 µg / kg body wt and an infusion thereafter of 0.5 – 3.0 µg / kg / hr. 
However, there is a problem with infusing Fentanyl for intraoperative 
anaesthesia – this highly lipid-soluble drug is significantly liable to accumulate 
in lipophilic peripheral tissues, with a resulting marked increase in the “context 
sensitive halftime “. 
 
a)   LOW DOSE   (2 µg / kg body wt)  
       In small doses, it is most useful for minor but painful surgical procedures. 
In   addition to analgesia during surgery, it may also provide some pain 
relief in the immediate postoperative period.  
b)   MODERATE DOSE (2 – 20 µg / kg body wt)  
In this dose, in addition to adequate analgesia, one would expect to see 
abolition of the stress response. However respiratory depression will be 
such that artificial ventilation during anaesthesia is necessary and careful 
observation of ventilation postoperatively is also essential. 
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c)   HIGH DOSE (25 – 50 µg / kg body wt) 
      This dose is usually used for open heart surgeries and certain complicated 
neurosurgical and orthopaedic surgeries where surgery is more prolonged 
and in the opinion of the anaesthesiologist, the stress response to surgery 
would be detrimental to the well being of the patient. This high dose along 
with N2O and O2 have been shown to attenuate the stress response as 
defined by increasing levels of circulating Growth Hormone, 
Catecholamines, ADH and Prolactin. 
3)  AS A GENERAL ANAESTHETIC 
                     When attenuation of the responses to surgical stress is especially 
important, doses of 50-100 µg/kg may be administered with O2 and muscle 
relaxant. This technique has been reported to provide anaesthesia without 
the use of additional anaesthetic agents. In certain cases, doses up to 150 
µg / kg body wt may be necessary to produce this anaesthetic effect.   
     4)  ADJUNCT TO REGIONAL ANAESTHESIA 
                     50 – 100 µg may be administered intramuscularly or slowly 
intravenously over one to two minutes, when additional analgesia is required.  
5)  POSTOPERATIVELY 
                      50 -100 µg may be administered intramuscularly for the control 
of pain, tachypnoea and emergence delirium. The dose may be repeated in one 
to two hours as needed.  
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TREATMENT OF OVERDOSAGE 
 
a) Hypoventilation / Apnoea :  Oxygen administration ,maintain patent airway      
with an oropharyngeal airway or by an endotracheal tube; assist or control 
the ventilation 
b) Truncal rigidity:  Intravenous neuromuscular blocking agents may be 
required to assistor control ventilation if it is affecting the respiration. 
c) Hypotension :  Appropriate parenteral fluids 
d) Respiratory depression :  Use opioid antagonists like Naloxone, Naltrexone,  
     Nalorphine, Levallorphan. 
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REVIEW OF LITERATURE 
 
 
  REID & BRACE (1940) postulated that reflex circulatory responses 
to laryngeal instrumentation were mediated through the vagus nerve and they 
named it as “Vaso Vagal Reflex”. 
 
 KING et al (1951) 24 used deep ether anaesthesia to abolish the reflex 
circulatory response to tracheal intubation. 
 
WYCOFF.C.C. (1960) 53 in his study stated that topical anaesthesia of 
the pharynx along with superior laryngeal nerve blocks reduced the increase in 
mean arterial pressure after intubation. 
 
STEIMHANS & GASKIN (1963) 48 found that intravenous lignocaine 
suppressed the cough reflex. It is very easy to predict that if the cough is 
suppressed, the rise in blood pressure, pulse rate and intracranial pressure 
noticed on laryngeal instrumentation would be blunted by this technique. 
 
FORBES and DALLY (1970) 16 observed that laryngoscopy and 
endotracheal intubation is immediately associated with an average increase in 
mean arterial pressure of 25 mmHg in all 22 normotensive patients. These 
responses were interpreted as due to reflex adrenal stimulation. 
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MASSON and ECKANKOFF (1971) proved that the hypertensive 
response in patients can be significantly decreased by simple lignocaine spray. 
 
PRYS ROBERTS et al (1971) 40 found that the increase in heart rate 
and blood pressure are much more exaggerated in hypertensive patients. 
 
       DENLINGER.J.K. and ELLISON.N.E. (1974) 10 have used 
intratracheal lignocaine spray which causes a 50% reduction in the 
hypertensive response. 
 
VICTORIA FARIA BLANC and NORMAND.A.G. (1974) in their 
article of “complications of tracheal intubation” have classified the 
neurogenic or reflexly mediated complication into three different categories. 
 
a) Laryngo Vagal Reflexes – which gives rise to spasm of the glottis, 
bronchospasm, apnoea, bradycardia, cardiac dysrhythmias and arterial 
hypotension. The mere presence of the tracheal tube seem to be the 
most common cause of bronchospasm in anaesthetized asthmatic 
patients. 
 
b) Laryngo Sympathetic Refexes – which include tachycardia, 
tachyarrhythmia and acute arterial hypertension as frequent 
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complications. The hypertensive, hyperdynamic state during 
laryngoscopy may be related in some cases to an increased nor-
adrenaline fraction of the total catecholamines. 
 
c) Laryngo Spinal Reflexes – which include coughing, vomiting and 
bucking. 
 
              TAMMISTO.T & AROMAA.U (1977) 52 has shown in his study that 
tolerance to the endotracheal tube is more rationally achieved by small doses 
of narcotic analgesics (e.g. fentanyl 0.5 to 1 µg / kg) than by increasing the 
dosage of thiopentone.  
 
              RYHANEN P, SAARELA E, SAUKKONEN J, HOLLMEN A 
(1977) 42 suggested that administration of a small prophylactic dose of 
Practolol is useful in preventing the excessive cardiovascular response due to 
laryngoscopy and tracheal intubation.   
 
              CURREN and CROWLEY M et al (1980) 8 in their study showed 
that Droperidol 150 µg/kg given intravenously before anaesthesia attenuated 
the pressor response to laryngoscopy and intubation. 
 34
           McCAMMON RL et al (1981) 28 showed in their study that intravenous 
Propranolol does not ensure protection against increases in HR and MAP 
associated with laryngoscopy and intubation of the trachea. 
 
            FASSOULAKI A, KANIARIS P (1983) 15 proved in their study that 
intranasal administration of nitroglycerine attenuates the pressor response to 
laryngoscopy and intubation of the trachea. 
 
TAM.S. et al (1985) 51 found attenuation of circulatory responses to 
laryngoscopy and endotracheal intubation using intravenous lignocaine; a 
determination of the optimal time as 3 minutes before intubation. 
 
             BATRA Y.K, INDU.B, PURI.G.D (1988) 4 observed that oral 
clonidine attenuated the pulse rate and blood pressure response to 
laryngoscopy and tracheal intubation. 
 
 DONALD.R.MILLER and RAYMOND.J.MARTINEAN (1989) 12 
used bolus dose of Esmolol for treating hypertension, tachycardia and 
myocardial ischaemia intraoperatively. 
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            NISHIKAWA T, NAMIKI A (1989) 36 proved in their study that 
intravenous Verapamil attenuates the pressor response to laryngoscopy and 
tracheal intubation. 
 
             HATANO Y, IMAI R, KOMATSU K, MORI K (1989) 21 showed in 
their study that intravenous administration of isosorbide dinitrate attenuates 
the pressor response to laryngoscopy and tracheal intubation. 
 
       T.NISHINO, K. HIRAGA and K. SUGIMORI (1990) 38 proved that 
lignocaine had a dose dependent effect on the extubation reflex, cough reflex 
in patients anaesthetized with enflurane, and that 1.5 mg/ kg of intravenous 
lignocaine can suppress the cough reflex and other related reflexes during 
intubation, extubation, bronchoscopy and laryngoscopy when duration of 
these procedures is relatively brief. 
 
              C.D.MILLER and S.J.WARREN (1990) 34 observed that intravenous 
lignocaine given within three minutes had no significant effect on 
cardiovascular effects of laryngoscopy and intubation. 
 
MIKAWA K, MAEKAWA N, GOTO R, KAETSU H, HASEGAWA 
M, YAKU H, OBARA H (1991) 29 showed that a bolus dose of Pindolol 4 µg 
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/ kg body wt is a simple, practical and effective method for attenuating 
cardiovascular responses to laryngoscopy and intubation. 
 
            MIKAWA K, MAEKAWA N, GOTO R, YAKU H, OBARA H, 
KASUNOKI M (1991) 31 concluded in their study that 2 or 3 mg / kg body wt 
of Diazoxide given 2.5 minutes before laryngoscopy attenuates pressor 
response to intubation. 
 
            MIKAWA K, MAEKAWA N, GOTO R, KAETSU H, , YAKU H, 
OBARA H (1991) 30 showed in their study that ATP 0.05 mg / kg or 0.1 mg / 
kg bolus injection is a simple, practical and effective method for attenuating 
the hypertensive response to laryngoscopy and tracheal intubation. 
 
           MIKAWA K, MAEKAWA N, GOTO R, KAETSU H, HASEGAWA 
M, YAKU H, OBARA H (1992) 32 concluded in their study that intravenous 
Mexiletine 3 mg / kg body wt is a simple method for attenuating pressor 
response to intubation. 
 
           SAITOH N and MIKAWA K et al (1992) 44 in their study found that 
intravenous Trimetaphan 0.05 – 0.1 mg / kg body wt given 1.75 min before the 
start of laryngoscopy may be used as a supplement during induction, to 
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attenuate the hypertensive response associated with laryngoscopy and tracheal 
intubation. 
 
           MIKAWA K and MAEKAWA N et al (1992) 33 in their study has 
concluded that oral Nilvadipine 2mg or 4mg before induction is a simple and 
practical method for attenuating pressor response to laryngoscopy and 
intubation. 
 
           CHUNG KS and SINATRA RS et al (1992) 7 in their study showed that 
Labetalol 0.4 mg/kg blunted the HR response to laryngoscopy and intubation 
during rapid sequence induction in healthy patients but had a minimal effect on 
Blood pressure. 
 
            LICKER M, FARINELLI C, KLOPFENSTEIN CE (1995) 26concluded 
in their study that thoracic epidural blockade combined with general 
anaesthesia was associated with preserved baroreflex function, and it afforded 
haemodynamic protection during laryngoscopy and intubation in the elderly. 
 
               DURRANI M, BARWISE JA, JOHNSON RF, KAMBAM JR, 
JANICKI PK (2000) 13 showed that intravenous chloroprocaine attenuates 
hemodynamic changes associated with direct laryngoscopy and tracheal 
intubation. 
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               KITAMURA T, YAMADA Y, CHINZEI M, DU HL, HANAOKA K 
(2001) 25 showed in their study that using the new intubation device 
Styletscope helps in the attenuation of hemodynamic responses to tracheal 
intubation. 
             
                YOO KY, JEONG ST, HA IH, LEE J (2003) 54 showed that Nitrous 
oxide attenuates pressor but augments norepinephrine response to 
laryngoscopy and endotracheal intubation. 
 
          GOYAGI T, TANAKA M, NISHIKAWA T (2005) 20 concluded in 
their study that continuous administration of Landiolol before tracheal 
intubation results in the attenuation of cardiovascular response for tracheal 
intubation. 
 
            DAHLGREN.N & MESSETER.K (1981) 9 in their study showed 
that fentanyl in the dose of 5 µg / kg body wt when given before induction 
with thiopentone and succinylcholine caused a significant attenuation of the 
blood pressure and pulse response to laryngoscopy and intubation.      
     
             DONAL.E.MARTIN (1982) 11 has also proved the efficacy of a 
low dose Fentanyl along with an induction dose of Thiopentone. But in these 
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series, it was found that the incidence and occurance of tachycardia was not 
prevented.         
     
.        KAUTTO VM (1982) 22 studied attenuation of circulatory response 
to laryngoscopy and intubation with Fentanyl 6µg / kg body wt had concluded 
that this dose completely abolished these responses. 
 
         MARTIN.D.E & ROSENBERG.H et al (1982) has showed that 
doses of fentanyl that are low enough to cause little postoperative respiratory 
depression significantly blunt postintubation hypertension when used as an 
adjunct to thiopental.  
 
           BLACK.T.E & KAY B et al (1984) 5 in their study showed that 
Alfentanyl in dose of 15 µg/kg reduces the cardiovascular responses to 
laryngoscopy and intubation and the effect appears to have a shorter duration 
than that of fentanyl 5µg/kg body wt. 
 
         CHUNG F & EVANS D (1985) 6 proved in their study that 
fentanyl 3 µg/kg when used as an adjunct to barbiturate induction, effectively 
lowered the thiopentone requirement and attenuated the pressor response to 
laryngoscopy and intubation. 
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        KAY B, T.E.I.HAECY and P.M.BOLDER (1985) compared 
Fentanyl and Nalbuphine in blocking the circulatory responses to 
laryngoscopy and tracheal intubation and found that nalbuphine attenuated 
mean pressure response to these manoeuvers but had no effect on the 
accompanying tachycardia whereas Fentanyl 5µg/kg prevents these responses 
however at the cost of significant decrease in both blood pressure and heart 
rate and increased incidence of respiratory depression.  
 
         FUSCIARDI.J & GODET.G et al (1986) 17 in their study on 
patients with stable angina undergoing operations of short duration has shown 
that fentanyl 3µg / kg plus a continuous intravenous nitroglycerin infusion, 0.9 
µg / kg / min in addition to thiopentone and pancuronium anaesthetic 
induction significantly decreases the incidence of myocardial ischemia 
associated with induction of anaesthesia and tracheal intubation. 
 
         LINDGREN L & SAARNIVAARA.L (1987) 27 in their study has 
proved that fentanyl in doses of 1 2 or 3 µg/kg body wt provided adequate 
protection against cardiac arrhythmias during induction of anaesthesia and 
also showed that it did not prevent the prolongation of QT interval after 
succinylcholine. 
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         ACALOVSCHI.I & SZILAGY.E et al (1989) 1 has proved that 
fentanyl in the dose of 5 µg/kg when used as preinduction agent to etomidate 
ensured the blockage of the pressor response to intubation, with hemodynamic 
stability during anaesthesia induction.   
 
         P.EBERT, JANES.D PEARSON.MD (1989) 14 compared the 
effects of placebo, Fentanyl and Esmolol and found the HR responses to 
laryngoscopy and intubation was more effectively blocked by Fentanyl while 
Esmolol better retained perfusion pressure. 
 
          SPLINTER WM, CERVENKO F (1989) 47 has concluded in their 
study that both Lignocaine and Fentanyl are recommended adjuncts to 
induction of anaesthesia with Thiopentone in geriatric patients.  
 
        SIMS C.H & SPLINTER W.M (1990) 45 in their study has proved 
that fentanyl blunts the hemodynamic response of children to laryngoscopy.     
   
      GAUBATZ CL & WEHNER R.J (1991) 18 concluded in their study 
that Esmolol in doses of excess of 1 mg/ kg appear to be necessary for 
effective control of heart rate. However when used with fentanyl, esmolol 
provides effective protection against the adrenergic response to laryngoscopy 
and intubation. 
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       SMITH J.E & KING.M.J et al (1992) 46 in their study has proved 
the effectiveness of Fentanyl 6µg/mg in attenuating the cardiovascular effects 
of fibreoptic intubation under general anaesthesia.   
 
       CHUNG.K.S, SINATRA.R, HARLEUY J.D, PAIGE D (1992) 7 
compared Fentanyl, Esmolol and their combination for blunting the 
haemodynamic responses during rapid sequence induction and concluded that 
the combination of low dose Fentanyl and Esmolol provides an alternative to a 
higher dose of Fentanyl for blunting the hemodynamic responses to 
laryngoscopy and intubation. 
 
      NISHINA.K & MIKAWA.K et al (1995) 37 in their study has shown 
that fentanyl 2 µg/kg attenuated the increases in HR, SBP and DBP more 
effectively than fentanyl 1 µg/kg and concluded that a bolus dose of fentanyl 2 
µg/kg given at the time of peritoneal closure was of value in attenuating the 
cardiovascular changes associated with tracheal extubation and emergence 
from anaesthesia, and that this treatment did not prolong the recovery.  
 
                   ADACHI.Y, TAKAMATSU.I & HARADA.M et al (1998) 3 in 
their study compared the effects of fentanyl 4 µg/kg, Pentazocine 0.5 mg / kg 
and buprenorphine 5 µg/kg administered 5 minutes before thiopentone 
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induction and concluded that only fentanyl 4 µg/kg diminished the circulatory 
responses of systolic blood pressure on the stimuli of endotracheal intubation.  
 
               PANG.W.W & LEI CH et al (1999) 39 showed in their study that 
Tramadol 3 mg/kg when given right before Thiopentone induction did not 
display a better attenuation against the increase of haemodynamic profiles 
than did Fentanyl 3µg/kg following tracheal intubation. 
 
              ADACHI YU & SATAMOTO.M et al (2002) 2 in their study has 
concluded that Fentanyl attenuates the hemodynamic response to endotracheal 
intubation more than the response to laryngoscopy. 
 
             SAHIHOGLU.Z & DEMIROLUK.S (2002) 43 compared the 
effects of fentanyl 1µg/kg, Alfentanyl 10µg/kg and Remifentanyl 1µg/kg 
followed by an infusion of 0.5 pg/kg/min in ASA physical status I & II 
morbidly obese patients and concluded that all the three had similar effects in 
controlling the haemodynamic response to tracheal intubation. 
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MATERIALS AND METHODS 
 
 
 
         A study was conducted to examine the optimal time for injecting small 
dose Fentanyl during anaesthetic induction to attenuate circulatory responses 
to laryngoscopy and endotracheal intubation in patients posted for elective 
ENT surgeries. The study comprised 80 patients in the age group 20 to 50 
years. Both male and female patients posted for ENT surgeries were 
included for the study. All the patients were informed of the study and prior 
written informed consent was obtained. The surgeon was also informed of 
the study. 
 
Patients were assessed by a detailed physical examination supported 
by investigations like routine blood tests- Hb, blood sugar, blood urea, 
serum creatinine, serum electrolytes, Chest X ray PA view, 
Electrocardiogram, etc. 
 
INCLUSION CRITERIA 
1) Patients in ASA physical status I & II 
2) Patients with modified Mallampatti scores I & II 
3) Age 20 to 50 years 
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EXCLUSION CRITERIA 
1) Patients in ASA physical status III & IV 
2) Patients with modified Mallampatti scores III & IV  
3) Patients with predicted difficult airway 
4) Obese patients 
5) Patients with Systemic Hypertension, Coronary Artery Heart 
Disease, H/O Cerebrovascular Accidents, Chronic Renal Failure, 
Valvular Heart Diseases, patients on antihypertensives or cardiac 
drugs 
6) Patients posted for emergency surgeries 
7) Patients with full stomach 
8) If the intubation time has exceeded 15 seconds 
9)   Age < 20 and > 50 years 
 
In this study, patients were randomly assigned into 4 groups: 
 
 Group I:  20 patients were given Inj Pentazocine (500 µg / kg body        
weight) 5minutes before intubation: which served as the 
control group.                                                               
Group  II:    20 patients were given Inj Fentanyl (2 µg / kg body weight)   
1 minute before intubation. 
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Group III:   20 patients were given Inj Fentanyl (2 µg / kg body weight) 
5   minutes before intubation. 
Group IV:  20 patients were given Inj Fentanyl (2 µg / kg body weight) 
10 minutes before intubation. 
 
ANAESTHESIA PROTOCOL 
 
              Preoperative visit was made to allay anxiety, and a good rapport was 
established with the patient. 
 
PREMEDICATION 
 
         All patients were given Tab Diazepam 10 mg orally the night before 
surgery. Tab Ranitidine 150 mg was given at 7 am on the morning of surgery. 
All patients were given Inj Glycopyrrolate 5 µg / kg body wt intramuscularly 
45 minutes before surgery. 
 
MONITORING      
    
             Patients were shifted to the operating room and connected to a standard 
multimonitor – ECG,    NIBP and pulse oximeter. NIBP was recorded every 
minute for the initial period up to 10 minutes after endotracheal 
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intubation.The average of the first two preoperative values recorded   3 
minutes apart were noted down which represented the operating room 
baseline values.  
 
INDUCTION AND INTUBATION 
 
          Patients were given Inj Fentanyl 2µg / kg body wt either 1 minute, 5 
minutes or 10 minutes before laryngoscopy and endotracheal intubation 
according to the group to which they were assigned. Patients in the control 
group received Inj.Pentazocine 500µg / kg body weight 5 minutes before 
intubation. Patients were preoxygenated for 3 minutes. A priming dose of 
Vecuronium Bromide (0.01mg / kg body wt) was given; followed 4 minutes 
later by Inj Thiopentone Sodium (5mg / kg body wt). Inj Vecuronium (0.1 mg 
/ kg body wt) was then given one minute after Thiopentone. Thereafter all the 
patients were manually ventilated with bag and mask with100% oxygen for 3 
minutes. Laryngoscopy and intubation was then done and the time taken for 
the same was noted. Those that took more than 15 seconds were excluded 
from the study. After confirmation of the endotracheal tube position, 
anaesthesia was maintained for the next 3 minutes with 67% Nitrogen and 
33% Oxygen. No surgical stimulation was permitted for 5 minutes after 
intubation. The baseline, preintubation, during intubation, 1 minute after 
 48
intubation and 3 minutes after intubation values of circulatory variables such 
as heart rate and systolic blood pressure were recorded.   
 
         Changes in each circulatory variable after tracheal intubation were based 
on the differences between baseline values and values obtained 1 minute after 
intubation. The baseline and 1 minute postintubation values of HR and SBP 
were compared. In addition these circulatory variables were compared among 
the groups. 
 
         Hypertension was defined as an increase in SBP more than 120% of the 
patient’s baseline value. Hypotension was defined as SBP less than 70 % of 
the patient’s baseline value. Tachycardia and bradycardia were defined as a 
heart rate greater than 120 bpm and less than 60 bpm respectively. A 
dysrhythmia was defined as any ventricular or supraventricular premature 
beat or any sustained rhythm that is other than sinus rhythm. Depression of 
spontaneous respiration before thiopentone was defined as a fall in SPO2 
value to less than 92% with an oxygen mask. Chest rigidity was defined as an 
increase in the resistance to bag and mask ventilation.  Delayed recovery was 
defined as the failure of the patient to wake up even 20 minutes after the 
termination of anaesthesia, thus preventing or delaying the extubation of the 
trachea. Postoperative respiratory depression was defined as a fall in 
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respiratory rate to less than 12 and a fall in SPO2 value to less than 92% in 
the post anaesthesia care unit.   
 
         The incidence of hypertension, hypotension, tachycardia, bradycardia, 
any dysrhythmias, depression of spontaneous respiration, delayed recovery 
and postoperative respiratory depression were recorded throughout the study 
period and in the immediate postoperative period and were compared among 
the groups. 
 
         All results were expressed as mean ± SD. The data were analysed using 
a repeated measures- analysis of variance ( ANOVA ) for within group 
comparisions. Differences among groups were analysed using a one-way 
ANOVA. A Tukeys test was used when a significant difference was indicated 
with the ANOVA procedure. Complication rates among patients were 
analysed using χ2 test. A  P value of < 0.05 was considered statistically 
significant.         
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OBSERVATION AND RESULTS 
 
 
             Eighty patients under this study were categorized into four groups, 20 
in each group. They comprised both sexes in the age group 20 to 50 years. 
The demographic profile is as follows:    
         
 AGE DISTRIBUTION                            
             
     AGE DISTRIBUTION IN THE FOUR GROUPS                           
Table 1                                                                           
   Age(yrs) 
 
   Group I    Group II   Group III   Group IV      Total 
21 – 30 
 
5 8 6 5 24 
31 – 40 
 
7 8 5 6 26 
41 – 50 
 
8 4 9 9 30 
                                                                             
                                                         
                                        
 AGE GROUP (yrs)                                                                    Table 2                       
Group N Mean Std. Deviation F-test 
Control 20 36.40 8.469 
Group II 20 33.05 9.006 
Group III 20 35.05 9.186 
Group IV 20 34.88 8.609 
  F=0.49 
     P=0.69 
      
  χ2=4.04   P=0.67 (P value of significance being < 0.05) 
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The age distribution between the four groups are equal – the difference is 
insignificant. (P=0.67).  
   SEX DISTRIBUTION                                                                                               
           Table 3 
 
    Sex 
 
Group I Group II Group III Group IV Total 
  
   Male 
 
9 8 10 13 40 
 
  Female 
 
11 12 10 7 40 
 
   χ2=2.80   P=0.42 (P value of significance being < 0.05) 
 
 
The sex distribution between the four groups are equal as shown in the bar 
chart, the difference being insignificant (P = 0.42).  
 
 
 
 
WEIGHT DISTRIBUTION (Kgs)                                       
                                                                                                    Table 4 
     GROUP 
N Mean(kgs) Sd F-test 
     
     Group I 20 52.85 3.774 
     
    Group II 20 52.95 3.576 
     
   Group III 20 52.70 3.570 
 
   Group IV 20 53.75 3.447 
 
 
F=0.34 
  P=0.79 
 
 
P value of significance being < 0.05. 
 
 
Weight distribution is also equal between these groups (P = 0.79) 
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The four groups that were included in the study were: 
Group I: 20 patients were given Inj Pentazocine (500 µg / kg body 
weight) 5minutes before intubation (Control) 
Group II:  20 patients were given Inj Fentanyl (2 µg / kg body weight) 1 
minute before intubation. 
Group III: 20 patients were given Inj Fentanyl (2 µg / kg body weight) 5       
minutes before intubation. 
Group IV: 20 patients were given Inj Fentanyl (2 µg / kg body weight) 
10 minutes before intubation.  
 
               The heart rate and systolic blood pressure were the circulatory 
variables that were measured in this study. The operation room baseline value 
of these two variables was noted first. The preintubation, during intubation, 1 
minute after intubation and 3 minutes after intubation values of these two 
variables were noted.   
                         There were no significant differences among the groups in the 
baseline values of systolic blood pressure and heart rate. There were 
significant differences among the groups with respect to the preintubation, 
during intubation, 1 minute and 3 minutes after intubation values of SBP and 
HR. Changes in SBP and HR was greatest 1 minute after intubation. Hence 
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these values were therefore used for comparison with the baseline values to 
determine whether there were intergroup as well as within group differences.     
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                                SYSTOLIC BLOOD PRESSURE CHANGES IN THE FOUR GROUPS 
                                                                                                                                                                                                          Table 
5 
 
             CONTROL 
 
            GROUP II            GROUP III            GROUP IV 
     SBP 
( mm Hg )  
     
     MEAN  SD MEAN SD MEAN SD MEAN SD 
 
BASELINE 
 
120.85 6.18 124.50 7.13 118.40 4.33 120.60 8.34 
 
PRE 
INTUBATION 
121.50 6.32 123.10 6.57 117.30 4.17 116.60 8.21 
 
DURING 
INTUBATION 
124.40 6.85 133.05 4.94 121.05 4.35 119.60 8.07 
 
1 MIN AFTER 
INTUBATION 
150.70 8.18 150.55 4.72 131.00 3.70 141.00 10.26 
 
3 MINS AFTER 
INTUBATION 
140.00 7.02 143.30 4.60 126.50 4.35 132.70 10.16 
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               SYSTOLIC BLOOD PRESSURE CHANGES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                            
 
 
            
 
                Table 5 shows the Mean SBP changes of all the four Groups 
recorded during the study. The graph depicts the Mean SBP values of all the 
four groups recorded in the study.  The baseline values of all the four groups 
was found to be more or less similar, as shown in the graph which was found 
to have no statistical difference between the four groups.    
 
                The preintubation value of Mean SBP in Group I was 121.5 ± 6.32 
mm Hg, which increased  124.40 ± 6.85 mm Hg during intubation. It further 
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   SBP 
 (mmHg) 
180 
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Group II 
Group III 
Group IV 
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increased to 150.70 ± 8.18 mm Hg 1 minute after intubation. This rise in mean 
SBP 1 minute after intubation when compared to the baseline value was 
statistically significant. It can be noted that the mean SBP did not return to 
near baseline value even 3 minutes after intubation. All the values remained 
above the other three groups.       
         
           The preintubation mean SBP in Group II was 123.10 ± 6.57 mm Hg 
which increased to 133.05 ± 4.94 mm Hg during intubation. The value further 
increased to 150.55 ± 4.72 mm Hg 1 minute after intubation. This increase in 
SBP from the baseline value was statistically significant. The mean SBP 
remained at 143.30 ± 4.60 mm Hg 3 minutes after intubation showing that the 
stress response was not significantly attenuated. All the values in Group II 
were just below the control group with the mean SBP 1 minute after intubation 
in both the groups more or less equal. The increase in mean SBP from baseline 
in both groups showed that there was no effective attenuation of pressor 
responses to intubation in both these groups.      
      
              In Group III, the preintubation mean SBP was 117.30 ± 4.17 mm Hg. 
This value increased to 121.05 ± 4.35 mm Hg during intubation. The value 
recorded 1 minute after intubation was 131.00 ± 3.70 mm Hg. This increase in 
mean SBP from baseline to 1 minute after intubation was not statistically 
significant. The value at 3 minutes after intubation was 126.50 ± 4.35 mm Hg. 
It can be seen from the graph above that the values in this group were below 
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the other three groups, proving that the pressor responses to laryngoscopy and 
intubation were better attenuated compared to the other three groups.   
   
                 In Group IV, the preintubation mean SBP was 116.60 ± 3.21 mm 
Hg, increasing to 119.60 ± 8.60 mm Hg during intubation. I minute after 
intubation, the mean SBP increased to 141.00 ± 10.26 mm Hg. This increase 
in mean SBP from baseline was not statistically significant. The mean SBP 3 
minutes after intubation was 132.70 ± 10.16 mm Hg. It can be seen from the 
graph that in group IV also there was attenuation of pressor responses to 
intubation next only to Group III but better than the other two groups.      
      
               It can be seen from the graph that the mean SBP after intubation 
returned to near the baseline values quicker in groups III and IV as shown by 
the values at 3 minutes after intubation, again proving that the pressor 
responses were better attenuated in these two groups when compared to the 
control group and group I.            
 
               The data obtained from all the four groups were analysed by the 
Repeated Measures of Variance (ANOVA) for within group comparisions. 
Differences among groups were analysed using a One Way ANOVA.(Table 
6)    
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REPEATED MEASURES OF ANOVA      
  
                                                                                                                                            
 
                                                                                                 Table 6 
 
SBP differences 
 
F Sig. 
 
Within group 
 
656.7 .001 
 
Between group 
 
16.666 .001 
 
 
(P value of significance being < 0.05) 
 
 
 
 
           A Tukey’s test was used when a significant difference was indicated 
with the ANOVA procedure. Table 7 shows the multiple comparisions among 
the four groups by the Tukey’s test.  There was no statistical difference 
between the control group and Group II (Fentanyl given I minute before 
intubation) [P > 0.05]. A statistically significant difference was observed 
between the control group and Group III (Fentanyl given 5 minutes before 
intubation) [P = 0.000]. There was also a statistically significant difference 
observed between the control group and Group IV (Fentanyl given 10 minutes 
before intubation) [P=0.026].  
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MULTIPLE COMPARISONS                                                                                        
                                                                                                     
                                                                                            Table 7 
        (I) group        (J) group 
Mean 
Difference (I-J) Sig. 
Control 
 Group II -3.41 .269 
 
 Group III 8.64(*) .000 
 
 Group IV 5.39(*) .026 
Group II 
 Control 3.41 .269 
 
 Group III 12.05(*) .000 
 
 Group IV 8.80(*) .000 
Group III 
 Control -8.64(*) .000 
 
 Group II -12.05(*) .000 
 
 Group IV -3.25 .310 
Group IV 
 Control -5.39(*) .026 
  
 Group II -8.80(*) .000 
 
 Group III 3.25 .310 
 
 
* The mean difference is significant at the 0.05 level. 
            
             The difference between Group III and Group IV was statistically 
insignificant, meaning that these two groups were more or less equal in their 
effort to attenuate the stress responses to intubation. But from the graph, since 
Group III has the least mean SBP values 1 minute after intubation, Group III 
showed the best attenuation of increase in SBP associated with intubation.                    
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HEART RATE CHANGES IN THE FOUR GROUPS 
                                                                                                                         
                                                                                                                                                                                                       
Table 8 
 
 
 
CONTROL 
 
GROUP II GROUP III GROUP IV HR 
( PER MINUTE)  
Mean SD Mean SD Mean SD Mean SD 
 
BASELINE 
 
78.60 5.28 77.30 6.30 77.00 6.82 77.60 6.67 
PRE 
INTUBATION 
 
83.30 3.76 69.90 4.13 74.20 5.62 67.45 4.29 
DURING 
INTUBATION 
 
102.05 8.36 98.60 11.41 81.80 4.05 84.00 6.99 
1 MIN AFTER 
 INTUBATION 
 
121.20 7.88 118.60 6.65 97.55 9.73 112.30 10.94 
3 MINS AFTER 
INTUBATION 
 
111.85 9.26 108.60 6.87 94.10 4.88 91.65 10.50 
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HEART RATE CHANGES 
                                                                                                                         
                                               
                                                                                                                                                      
   
 
                                        Table 8 shows the mean HR changes of all the four groups 
including the baseline value and that recorded during the study – preintubation, 
during intubation, one minute and three minutes after intubation. The graph below is 
a graphical representation of these values. From the graph, it can be noted that the 
baseline mean HR in all the four groups were more or less similar and there was no 
statistical difference between the groups with regard to the baseline value.      
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           In Group I or the control group, the preintubation mean HR was 83.30 
± 3.76 per minute, which increased to 102.05 ± 8.36 per minute during 
intubation. The mean HR further increased to 121.20 ± 7.88 per minute. This 
increase in HR from baseline is statistically significant. The mean HR three 
minutes after intubation was 111.85 ± 9.26 per minute. There was no 
attenuation of stress response in the control group, and all the values in this 
group remained above the other three groups. 
 
              In Group II where fentanyl was given one minute before intubation, 
the preintubation mean HR was 69.90 ± 4.13 per minute. The mean HR 
increased to 98.60 ± 11.41 per minute during intubation. The mean HR at I 
minute after intubation was 118.60 ± 6.65 per minute and this increase from 
the baseline value was statistically significant. The mean HR remained at 
108.60 ± 6.87 per minute three minutes after intubation.  
 
                In Group III, the preintubation value was 74.20 ± 5.62 per minute. 
The mean HR increased to 81.80 ± 4.05 per minute during intubation. This 
further increased to 97.55 ± 9.73 per minute one minute after intubation.The 
increase in mean HR from the baseline was statistically not significant. The 
mean HR came to 94.10 ± 4.88 per minute three minutes after intubation. 
From the graph it can be noted that the values remained significantly closer to 
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the baseline value, meaning that the stress response to intubation was better 
attenuated in this group.     
          The preintubation mean HR in Group IV was 67.45 ± 4.29 per minute 
which increased to 84.00 ± 6.99 per minute during intubation. This further 
increased to 112.30 ± 10.94 per minute one minute after intubation. This 
increase from baseline was statistically not significant. The mean HR three 
minutes after intubation was 91.65 ± 10.50 per minute. In this group also, the 
stress response was attenuated, but less than Group III and significantly better 
than the other two groups.       
           The mean HR returned to near the baseline value in Groups III & IV 
much earlier than the other two groups, meaning that better hemodynamic 
stability was attained in Groups III & IV.  
           The data of mean HR values from the four groups were analysed by the 
Repeated Measures of ANOVA for within group comparisions. Differences 
among groups were analysed using a one way ANOVA (Table 9).    
REPEATED MEASURES OF ANOVA 
                                                                                                                           
                                                                                                    Table 9 
 
HR differences F Sig. 
 
Within group 501.6 .001 
 
Between group 43.6 .001 
 
           (P value of significance being < 0.05) 
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           Both the HR differences within group (P = 0.001) and between group       
(P = 0.001) were found to be statistically significant.         
            A Tukey’s test was used when a significant difference was indicated 
with the ANOVA procedure. Table 10 shows the multiple comparisions 
among all the four groups. A statistically significant difference was observed 
between the groups except between Group III & Group IV.  
 
MULTIPLE COMPARISONS 
 
                                                                                                        
Table 10                                       
        (I) group         (J) group 
Mean 
Difference (I-J) Sig. 
Control 
 Group II 4.80(*) .008 
  Group III 14.47(*) .000 
  Group IV 12.80(*) .000 
Group II  Control -4.80(*) .008 
  Group III 9.67(*) .000 
  Group IV 8.00(*) .000 
Group III  Control -14.47(*) .000 
 
 Group II -9.67(*) .000 
 
 Group IV -1.67 .662 
Group IV 
 Control -12.80(*) .000 
 
 Group II -8.00(*) .000 
 
 Group III 1.67 .662 
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* The mean difference is significant at the 0.05 level. 
 
 COMPLICATIONS     
                                                                  
              The complications noted during the study were hypertension, 
tachycardia, bradycardia, truncal rigidity, depression of spontaneous 
respiration, dysrhythmia, delayed recovery and post operative respiratory 
depression. (Table 11)      
                                                                                                                    Table 11 
 
COMPLICATIONS 
 
 
  GROUP 
I 
 
  GROUP 
II 
 
 GROUP 
III 
 
 GROUP 
IV 
 
     Sig 
 
Tachycardia 
 
 
        10 
 
          8 
 
         1 
 
         6 
χ2= 0.41 
 
P = 0.02 
 
Bradycardia 
 
 
          0 
 
          5 
 
        9 
 
         12 
χ2 = 0.34 
 
P = 0.04 
 
Hypertension 
 
 
        12 
 
        5 
 
        2 
 
        5 
χ2= 2.86 
 
P= 0.004 
 
Hypotension 
 
 
         0 
 
        0 
 
        0 
 
        0 
 
     NIL 
 
Chest rigidity 
 
         0 
 
        0 
 
        1 
 
        1 
χ2 = 2.05 
 
P = 0.56 
 
Dysrhythmia 
 
 
         2 
 
        1 
 
        2 
 
        0 
χ2 = 2.35 
 
P = 0.50 
Depression of 
Spontaneous 
ventilation 
 
0 
 
0 
 
1 
 
5 
χ2 = 1.32 
 
P = 0.03 
 
Delayed recovery 
 
 
0 
 
0 
 
0 
 
0 
 
    NIL  
Post operative 
Respiratory 
depression 
 
0 
 
0 
 
1 
 
0 
χ2 = 2.12 
 
P = 0.42 
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  (P value of significance being < 0.05)                                                    
           
          The incidence of tachycardia was high in the control group and in 
Group II and lowest in Group III. This difference was statistically significant.   
 
          There was a high incidence of bradycardia in Group IV (12 patients), 
followed by Group III with 9 patients. There was no case of bradycardia in 
the control group. The hemodynamic stability was not affected in any of these 
patients and only 4 out of the 26 patients actually required Inj Atropine 
sulphate 0.6 mg IV to treat it. The difference was statistically significant.  
 
           Control group had the highest incidence of hypertension (12 patients), 
followed by Group II and Group IV with 5 patients each. Group III had the 
least incidence (2 patients). This difference was statistically significant.          
Hypotension was not noted in any of the patients in the four groups. 
 
          There were two cases of chest rigidity, one each in groups III and IV. 
Both these patients were effectively managed with bag and mask ventilation.  
 
           Dysrhythmias occurred in 5 cases. All of these were ventricular 
ectopic beats, which disappeared spontaneously without any intervention. 
There was no haemodynamic instability in any of these five patients. 
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            Depression of spontaneous ventilation as noted by a fall in the SPO2 
value to less than 92 % in room air occurred in 5 cases in group IV and in 1 
patient in group III. These patients were then given assisted ventilation with 
bag and mask in 100 % oxygen. This difference was statistically significant. 
 
             There was no case of delayed recovery in any of the groups. There 
was 1 patient in group III who had post operative respiratory depression, as 
noted by the fall in SPO2 value to less than 92% in room air, 20 minutes after 
extubation. He was effectively managed with 100% O2 in Venturi mask at the 
Post operative care unit. However, there was no statistically significant 
difference.   
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DISCUSSION 
 
 
 
 
                  Laryngoscopy and tracheal intubation are usually accompanied by 
increases in arterial blood pressure and heart rate 29. This response is 
undesirable, especially in patients with cardiovascular and intracranial 
disease. Increase in heart rate and blood pressure occurs most commonly from 
reflex sympathetic discharge in response to laryngotracheal stimulation, 
which in turn leads to increased norepinephrine levels.    
                  
                  Induction of anaesthesia is a critical phase in the anaesthetic 
procedure. Sympathetic response, coughing and straining during 
laryngoscopy and endotracheal intubation should be avoided. The transient 
nature of hypertension and tachycardia, that usually lasts about 10 minutes 
during laryngoscopy and intubation, might be the reason for the fewer 
incidences of complications in the normotensive patient. However in patients 
with compromised heart or with neurological disease, such transient nature of 
hypertension may itself precipitate heart failure and intraventricular 
haemorrhage.         
              
                       Many methods have been suggested to attenuate the circulatory 
responses to laryngoscopy and endotracheal intubation. They are the use of 
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inhaled anaesthetics 35, sympathetic blockers 44, vasodilators 49, local 
anaesthetics 50, narcotics 3 and a combination of these drugs.   
 
                    Many studies have reported a beneficial effect of fentanyl as an 
adjunct to barbiturate induction. Dahlgren and Messeter 9 have shown that 5 
µg / kg of fentanyl given before intubation effectively blunts the 
cardiovascular stress responses to intubation in neurosurgical patients. Using 
8 µg / kg fentanyl preloading, Martin et al. 11 demonstrated that fentanyl 
abolishes both the heartrate and blood pressure increases related to tracheal 
intubation and prevents an increase of pulmonary capillary wedge pressure 
during the induction of anaesthesia with thiopentone.  
 
         .       Nishina.K & Mikawa.K et al (1995) 37 in their study has shown that 
fentanyl 2 µg/kg attenuated the increases in HR, SBP and DBP more 
effectively than fentanyl 1 µg/kg and concluded that a bolus dose of fentanyl 
2 µg/kg given at the time of peritoneal closure was of value in attenuating the 
cardiovascular changes associated with tracheal extubation and emergence 
from anaesthesia, and that this treatment did not prolong the recovery.  
 
                 Adachi.Y, Takamatsu.I & Harada.M et al (1998) 2 in their study 
compared the effects of fentanyl 4 µg/kg, Pentazocine 0.5 mg / kg and 
buprenorphine 5 µg/kg administered 5 minutes before thiopentone induction 
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and concluded that only fentanyl 4 µg/kg diminished the circulatory responses 
of systolic blood pressure to the stimulation of endotracheal intubation. 
Unlike sympathetic blockers, vasodilators and local anaesthetics, fentanyl can 
produce potentially disturbing side effects, such as skeletal muscle rigidity 
and postanaesthetic respiratory depression. Chung and Evans 6 investigated 
the effects of 3µg/kg of fentanyl in geriatric patients and found that, fentanyl 
attenuated increases in heart rate and arterial pressure during the first minute 
after intubation, compared with controls. 
             
                   Since fentanyl in large doses that were initially used to attenuate 
circulatory responses to intubation produce many side effects, small dose 
Fentanyl is increasingly being used to effectively attenuate the stress response 
during anaesthetic induction. However there has been no evaluation of the 
optimal time of injection of small dose Fentanyl to effectively obtund the 
secondary circulatory responses to laryngoscopy and endotracheal intubation. 
Hence this study was designed to evaluate the optimal time for injecting small 
dose Fentanyl to effectively attenuate the circulatory responses accompanying 
laryngoscopy and intubation during anaesthetic induction. For this study I 
used Inj. Fentanyl 2 µg / kg body weight before induction based on the study 
made by Nishina.K & Mikawa.K et al (1995) 37 who showed that this dose 
effectively blunted the increase in SBP, DBP, MAP and HR that accompanies 
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laryngoscopy and intubation. Young et al (1998) 55 had done a similar study 
using Fentanyl 2µg/kg to obtund the intubation response.    
          
            I compared the effectiveness of fentanyl given 1 minute, 5 minutes 
and 10 minutes before intubation in obtunding the stress response to 
intubation, as shown by the increase in SBP and HR that follows 
laryngoscopy and intubation. I compared the effectiveness between the three 
groups and also with a control group which did not receive fentanyl. Since the 
maximum stress is at one minute after intubation, I took it as the cut off point 
to compare the effectiveness in attenuating the increase in SBP and HR from 
the baseline.    
 
  SYSTOLIC BLOOD PRESSURE CHANGES 
                     
                       In the study done by Young et al 55, the control group did not 
receive fentanyl. Since we routinely use Inj. Pentazocine as an analgesic 
during induction of anaesthesia for most of the cases in our hospital, I used 
Pentazocine in the control group. The stress response to laryngoscopy and 
intubation was not attenuated in the control group as shown by the statistically 
significant increase in the mean SBP value (150.7±8.18 mmHg) recorded at 1 
minute after intubation from the baseline. This finding was in concordance 
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with the study done by Young et al 55 as well as with the study done by 
Adachi et al 3. 
 
                      In group II where fentanyl was given 1 minute before 
intubation, the increase in mean SBP from baseline to 1 minute after 
intubation (150.55±4.72 mmHg) was also statistically significant, indicating 
that the stress response to laryngoscopy and intubation was not adequately 
obtunded. This finding was also in concordance to the study by Young et al 
(151±14 mmHg). 
 
                       When fentanyl was given 5 minutes before intubation as in 
Group III, the increase in mean SBP from baseline to 1 minute after 
intubation was the least among the four groups (131±3.7 mmHg). This 
increase was not statistically significant proving that the pressor response to 
laryngoscopy and intubation was adequately obtunded in this group. This 
finding was also in accordance with the study by Young et al. This finding 
also correlated well with the study of Chung & Evans 6, as well as with 
Splinter & Cervenko 47.  
 
                       In Group IV, the increase in mean SBP recorded at 1 minute 
after intubation from the baseline value (141±10.26 mmHg) was statistically 
not significant. This showed that the pressor response to intubation was 
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adequately attenuated in this group. This finding however was not in 
concordance with the study by Young et al (151±26). 
 
                    From the above findings, both Group III and Group IV showed 
adequate attenuation of stress response to laryngoscopy and intubation. 
Multiple comparisions among the four groups by the Tukeys test (Table 7) 
showed that there was no statistical difference between groups I and II, as 
well as between Groups III and IV. 
 
                   Since the increase in mean SBP at 1 min after intubation was the 
least in Group III, it can be concluded that the pressor response to 
laryngoscopy and intubation is best attenuated when Fentanyl is given 5 
minutes before intubation, which is consistent with the peak analgesic effect 
of Fentanyl.  
         
HEART RATE CHANGES 
 
              In the control group, the increase in mean heart rate recorded 1 
minute after intubation from the baseline was statistically significant 
(121.2±7.88). This increase was the highest recorded among the four groups 
showing that there was no attenuation of stress response to laryngoscopy and 
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intubation. This finding was in concordance with the study done by Young et 
al and by Adachi et al. 
 
               In Group II, there was a statistically significant increase in the mean 
heart rate from the baseline to that recorded at 1 minute after intubation 
(118.6±6.65). This increase was the second highest recorded among the 
groups. This showed that there was no attenuation of stress response in 
Group II as well. This finding was in concordance with the finding by Young 
et al. 
 
                   Patient in Group III who received Fentanyl 5 minutes before 
intubation showed adequate attenuation of stress response as shown by the 
increase in heart rate from baseline which was not statistically significant 
(97.55±9.73). Also, it can be recalled from the graph that the value recorded 
is the least among the groups. This finding was also in concordance with the 
study made by Young et al. 
 
             In group IV, the increase in heart rate from the baseline to 1 minute 
after intubation was not statistically significant (112.3±10.94). This shows 
that there was adequate attenuation of stress response to laryngoscopy and 
intubation in patients receiving fentanyl 10 minutes before intubation. This 
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finding was not in concordance with Young et al who showed that there was 
no adequate attenuation in this group. 
 
             In table 10, the multiple comparisions among groups showed that 
there was no statistically significant difference between groups III and IV. In 
this study, both Group III and Group IV showed adequate attenuation of 
stress response to laryngoscopy and intubation. Since the increase in mean 
heart rate was the least in Group III, it can be concluded that the attenuation 
of stress response to laryngoscopy and intubation is best achieved by giving 
low dose fentanyl 5 minutes before intubation, which is consistent with its 
peak analgesic effect. This finding was in concordance with the study by 
Young et al.      
 
COMPLICATIONS 
 
             Hypertension was defined as an increase in SBP more than 120% of 
the patient’s baseline value. Hypotension was defined as SBP less than 70 % 
of the patient’s baseline value. Tachycardia and bradycardia were defined as a 
heart rate greater than 120 bpm and less than 60 bpm respectively. A 
dysrhythmia was defined as any ventricular or supraventricular premature 
beat or any sustained rhythm that is other than sinus rhythm. Depression of 
spontaneous respiration before thiopentone was defined as a fall in SPO2 
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value to less than 92% with an oxygen mask. Chest rigidity was defined as an 
increase in the resistance to bag and mask ventilation.  Delayed recovery was 
defined as the failure of the patient to wakeup even 20 to 30 minutes after the 
termination of anaesthesia, thus preventing or delaying the extubation of the 
trachea. Postoperative respiratory depression was defined as a fall in 
respiratory rate to less than 12 and a fall in SPO2 value to less than 92% in 
the post anaesthesia care unit. These complications were recorded throughout 
the study period and compared among the groups.    
 
                Hypertension occurred mostly in Groups I and II (12 and 5 
respectively). This difference was statistically significant. This showed that 
the attenuation to pressor response to laryngoscopy and intubation was not 
adequate in these two groups. This was in concordance to the study done by 
Young et al. Only 7 out of the 40 patients in groups III and IV had 
hypertension, proving that the stress response was better obtunded in these 
two groups. 
 
                Tachycardia also followed the same pattern showing higher 
incidence in groups I and II (10 and 8 respectively). This was also statistically 
significant. Group III (1patient) had the least incidence followed by Group IV 
(6 patients), again proving that there was better attenuation of stress response 
in these groups. This was also in accordance to Young et al. 
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                Peroperative bradycardia occurred commonly in groups III and IV 
(9 and 12 respectively). There was no case of bradycardia in the control 
group. This also was in concordance to the study by Young et al. Bradycardia 
is a well recognized side effect of fentanyl. In this study, though 26 patients 
had bradycardia, none of them resulted in any haemodynamic instability. 
Only 4 required Inj Atropine sulphate 0.6 mg IV stat to treat it. 
 
               Truncal rigidity or chest rigidity was seen in 2 patients (1 each in 
groups III and IV). This is also another recognized troublesome side effect of 
fentanyl. But in both these cases, there was no interference with ventilation, 
and it was effectively managed with bag mask assisted ventilation. This was 
statistically not significant. Young et al in his study had no case of chest 
rigidity in his patients.  
 
               Dysrhythmias were noted in only 5 patients, 2 in Group I, 1 in 
Group II and 2 in Group III. All of these were ventricular premature beats. 
None of these cases had hemodynamic instability. All of these disappeared 
spontaneously. There was no statistically significant difference. Young et al in 
his study noted dysrhythmias mainly in the control group. Lindgren and 
Saarnivaara (1987) 27 in their study proved that fentanyl in doses of 1, 2 or 
3µg/kg body wt provided adequate protection against cardiac arrhythmias 
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during induction of anaesthesia. But in my study, I noted dysrhythmias in 3 of 
the fentanyl treated patients. 
 
                Depression of spontaneous ventilation occurred mostly in Group IV 
(5 patients). This is also a well recognized side effect of fentanyl. Since the 
time interval between administering fentanyl and the actual anaesthetic 
induction was high (around 7-8 minutes) in Group IV, this might be the 
reason for the higher incidence of this complication in this group. In my 
study, none of the patients in all the groups were left unattended after giving 
fentanyl remembering this potential complication. Once the SPO2 fell to 92% 
in room air, 100% O2 was administered through bag and mask. 
              Post operative respiratory depression occurred in only 1 patient in 
Group III. This is also a recognized side effect of Fentanyl. He was efficiently 
managed at Post anaesthesia care unit. He eventually recovered in one hour. 
This was also not statistically significant.     
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SUMMARY 
 
               This study evaluated the optimal time for administering Fentanyl in 
the dose of 2 µg / kg body wt, in attenuating the stress response to 
laryngoscopy and intubation during anaesthetic induction. 
             
               From the data, it was found that both the Systolic blood pressure and 
heart rate changes that follow laryngoscopy and intubation were well 
obtundated, when fentanyl was given 5 minutes before intubation. Also, it was 
observed that the complications due to fentanyl were minimum in this group. 
 
               The study thus shows that, Inj Fentanyl 2 µg / kg body wt when 
given 5 minutes before intubation showed the maximum attenuation of the 
hemodynamic responses that accompany laryngoscopy and endotracheal 
intubation during anaesthetic induction. 
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CONCLUSION 
 
 Fentanyl in the dose of 2µg/kg body weight when given 5 minutes before 
intubation adequately attenuates the circulatory response to laryngoscopy and 
endotracheal intubation without producing major complications. 
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                           CONTROL GROUP –HEART RATE 
CHANGES (beats per minute) 
                 CONTROL GROUP – SYSTOLIC BLOOD 
PRESSURE CHANGES (mm Hg) 
                                            HEART RATE ( per minute) 
l 
o 
 
   Name 
  
 
 Age 
( yrs) 
 
 Sex  
 
 Weight 
   (kgs) 
 
 Baseline 
 
Pre 
Intubation 
 
During 
Intubation 
 
1 min after 
intubation 
 
3 min a
intubat
1 Kumar 48    M 55 74 76 102 124 12
2 Rekha 36    F 56 76 81 104 109 10
3 Karthik 25   M 52 82 88 112 128 12
4 Perumal 44   M 58 80 84 106 108 10
5 Kasthuri 32    F 45 88 88 118 132 12
6 Ramanan 41   M 51 86 84 96 116 11
7 Mangamma 37    F 50 84 82 120 140 13
8 Suresh 22   M 55 80 86 92 118 10
9 Ramani 46    F 56 82 88 103 128 11
10 Rajendran 38   M 55 78 84 89 118 11
11 Kavitha 27    F 48 76 82 104 116 10
12 Balaji 44   M 50 72 80 102 115 9
13 Suganthi 28    F 56 70 82 98 124 10
14 Ponnaiyan 48   M 58 68 75 112 118 10
15 Akila 33    F 54 78 82 96 122 10
16 Madhavan 45   M 58 74 80 98 114 10
17 Mariammal 35    F 52 78 84 102 126 12
18 Rukmani 41    F 50 80 86 100 116 10
19 Fathima 37    F 50 82 86 94 124 11
20 Jennifer 21    F 48 84 88 93 128 12
SYSTOLIC BLOOD PRESSURE (mmHg)  
  Name 
  
 
 Age 
( yrs) 
 
 Sex  
 
 Weight 
   (kgs) 
 
 aseline 
 
Pre 
Intubation 
 
During 
Intubation 
 
1 min after 
intubation 
 
3 min
intuba
1 Kumar 48 M 5  112 112 136 1 6 1
2 Rekha 36 F 56 110 110 110 130 1
3 Karthik 25 M 52 12  124 126 158 1
4 Perumal 4  M 58 12  118 120 144 1
5 Kasthuri 32 F 45 124 122 124 156 1
6 Ramanan 41 M 51 130 126 126 55 
7 Mangam a 37 F 50 132 134 136 162 1
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                                                 GROUP II–HEART RATE 
CHANGES (beats per minute) 
                                                                 
 
                          GROUP II – SYSTOLIC BLOOD 
PRESSURE CHANGES (mm Hg) 
8 Suresh 22 M 55 132 132 132 158 1
9 Ramani 46 F 56 124 124 124 155 1
10 Rajendran 38 M 55 124 126 128 160 1
11 Kavitha 27 F 48 122 130 134 146 1
12 Balaji 44 M 50 120 118 120 150 1
13 Suganthi 28 F 56 112 116 122 148 1
14 Ponnaiyan 48 M 58 118 118 120 140 1
15 Akila 33 F 54 116 114 116 154 1
16 Madhavan 45 M 58 115 118 118 153 1
17 Mariammal 35 F 52 118 120 118 140 1
18 Rukmani 41 F 50 120 122 124 158 1
19 Fathima 37 F 50 124 122 124 156 1
20 Jennifer 21 F 48 122 124 130 145 1
                                      HEART RATE (per minute) 
 
 
   Name 
  
 
 Age 
( yrs) 
 Sex  
 
 Weight 
   (kgs) 
 
 Baseline 
 
Pre 
Intubation 
 
During 
Intubation 
 
1 min after 
intubation 
 
3 min
intuba
1 Meenatchi 42 F 50 76 68 96 122 
2 Shanthi 22 F 54 78 72 98 124 
3 Sundari 33 F 56 84 70 96 132 
4 Shankar 24 M 53 86 72 92 126 
5 Rajeshwari 25 F 50 88 74 88 128 
6 Vijayan 31 M 54 82 72 84 122 
7 Varalakshmi 34 F 50 80 72 88 116 
8 Devendran 27 M 48 78 70 92 118 
9 Rani 35 F 54 74 68 84 108 
10 Nirmala 28 M 48 72 66 88 112 
11 Mani 36 F 56 76 70 92 116 
12 Eswaran 21 M 50 84 80 96 122 
13 Lakshmi 48 F 58 82 74 94 116 
14 Govindammal 48 F 60 84 74 98 128 
15 Rangarajan 49 M 58 68 64 118 116 
16 Selvam 37 M 56 68 62 114 118 
17 Chitra 38 F 50 68 66 118 114 
18 Arockiyamary 37 F 50 74 68 114 112 
19 Balu 21 M 54 70 66 112 110 
20 Maragatham 25 F 50 74 70 110 112 
SYSTOLIC BLOOD PRESSURE (mmHg) 
o 
 
    
  
  
  
    
 
 Baseline 
 
Pre 
Intubation 
 
i  
t ti  
 
 i  t  
i t ti  
 
 i  
i t
1 eenatchi 42 F 50 2 2 2  144 14
2 Shanthi 22 F 54 0 2 24 140 13
3 Sundari 33 F 56 6 14 24 148 13
4 Shankar 24 M 53 2 0 6 154 14
5 Rajeshwari 25 F 50 124 124 130 154 14
6 Vijayan 31 M 54 128 126 132 150 14
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                                              GROUP III–HEART RATE 
CHANGES (beats per minute) 
                          GROUP III – SYSTOLIC BLOOD 
PRESSURE CHANGES (mm Hg) 
7 Varalakshmi 34 F 50 130 128 132 152 14
8 Devendran 27 M 48 134 132 136 158 14
9 Rani 35 F 54 134 134 138 159 15
10 Nirmala 28 M 48 130 130 134 150 14
11 Mani 36 F 56 124 124 132 144 14
12 Eswaran 21 M 50 126 124 136 150 14
13 Lakshmi 48 F 58 128 124 136 152 14
14 Govindammal 48 F 60 130 126 134 150 14
15 Rangarajan 49 M 58 132 130 134 156 14
16 Selvam 37 M 56 124 122 139 146 14
17 Chitra 38 F 50 126 124 134 150 14
18 Arockiyamary 37 F 50 128 126 134 150 14
19 Balu 21 M 54 118 116 140 154 14
20 Maragatham 25 F 50 114 114 140 150 14
                                    HEART RATE (per minute) 
l 
No 
 
   Name 
  
 
 Age 
( yrs) 
 
 Sex  
 
 Weight 
   (kgs)
 
 Baseline 
 
Pre 
Intubation 
 
During 
Intubation 
 
1 min after 
intubation 
 
3 min a
intubat
1 Muthu 32 M 56 76 7  80 96 9
2 A andan 44 M 55 78 70 82 100 9
3 Jarina 35 F 50 86 76 86 102 9
4 Shantha 41 F 56 88 78 86 104 0
5 Asokan 21 M 53 82 84 92 124 0
6 Lalitha 45 F 57 80 84 84 102 0
7 Kumar 28 M 54 78 80 84 98 9
8 Bhuvana 46 F 50 74 74 82 98 9
9 Gokul 33 M 56 72 76 80 102 9
10 Nalini 22 F 48 76 70 80 98 9
11 Ramalingam               48 M 53 84 72 82 94 9
12 Renuka 24 F 45 82 80 82 98 9
13 Pushpa 49 F 50 68 76 84 96 9
14 Sivaraman 36 M 50 84 68 80 69 8
15 Revathy 41 F 55 84 80 86 102 9
16 Monica 25 F 48 64 66 74 92 9
17 Angamuthu           44 M 57 74 72 78 98 9
18 Katherine 22 F 50 70 72 80 96 9
19 Krishnan 42 M 57 74 70 78 94 9
20 Balan 36 M 54 66 64 76 88 9
   SYSTOLIC BLOOD PRESSURE (mmHg) 
o 
 
  Name 
  
 
 Age 
( yrs) 
 
 Sex  
 
 Weight
   (kgs) 
 
 aseli e 
 
Pre 
Intubation 
 
During 
Intubation 
 
1 min after 
intubation 
 
3 min
intuba
1 Muthu 32 M 56 110 112 115 132 1
2 Anandan 4   5  112 110 116 124 1
3 Jarina 35 F 50 120 116 12  132 1
4 Shantha 41 F 56 122 120 12  134 1
5 Asokan 21 M 53 124 122 128 136 1
6 Lalitha 45 F 57 118 116 124 130 1
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                                  GROUP IV–HEART RATE 
CHANGES (beats per minute) 
                                 GROUP IV – SYSTOLIC BLOOD 
PRESSURE CHANGES (mm Hg) 
7 Kumar 28 M 54 116 116 114 128 1
8 Bhuvana 46 F 50 114 114 116 126 1
9 Gokul 33 M 56 120 118 122 132 1
10 Nalini 22 F 48 126 126 126 138 1
11 Ramalingam               48 M 53 122 120 124 130 1
12 Renuka 24 F 45 124 124 122 132 1
13 Pushpa 49 F 50 118 116 120 128 1
14 Sivaraman 36 M 50 116 116 118 128 1
15 Revathy 41 F 55 112 110 114 136 1
16 Monica 25 F 48 118 116 120 128 1
17 Angamuthu           44 M 57 122 120 124 136 1
18 Katherine 22 F 50 120 120 124 132 1
19 Krishnan 42 M 57 118 118 122 130 1
20 Balan 36 M 54 116 116 120 128 1
                                     HEART RATE (per minute) 
Sl 
No 
 
   Name 
  
 
 Age 
( yrs) 
 
 Sex  
 
 Weight 
   (kgs) 
 
 Baseline 
 
Pre 
Intubation 
 
During 
Intubation 
 
1 min after 
intubation 
 
3 min a
intubati
1 R vi 22 M 52 74 68 92 122 108
2 Mumtaz 34 F 54 82 64 96 112 96
3 Ponnan 39 M 56 86 74 88 112 94
4 Rani 42 F 52 68 62 84 100 88
5 Padhmanaban       33 M 58 72 65 88 126 104
6 Pradeep 25 M 50 66 60 86 94 78
7 Kanagaraj 45 M 54 70 72 94 97 76
8 Punithavathy                 28  F 50 74 68 90 100 88
9 Kathiravan             35 M 58 78 71 88 104 96
10 Muniyappan 21 M 55 82 69 82 110 92
11 Dinesh 35 M 60 86 62 68 132 108
12 Gowri 24 F 50 84 70 74 114 102
13 Senthil 42 M 58 80 72 78 105 92
14 Sudha 38 F 50 88 74 84 118 90
15 Sultan 26 M 50 82 66 76 122 88
16 Mercy 41 F 48 84 62 78 124 92
17 Muthu 44 M 54 68 64 82 104 86
18 Boopathy 32 M 53 74 68 80 114 78
19 Esther 48 F 56 76 72 84 108 72
20 Vijayanand                    34 M 57 78 66 88 128 105
SYSTOLIC BLOOD PRESSURE  
   Name 
 
 
 Age 
( yrs) 
 
 Sex  
 
 Weight 
   (kgs) 
 
Pre 
Intubation 
 
During 
Intubation 
 
1 min after 
intubation 
 
3 m
in u
Ravi 22 M 52 110 108 112 130 
Mumtaz 34 F 54 112 108 110 136 
Ponnan 39 M 56 122 118 116 142 
Rani 42 F 52 120 122 124 139 
Padhm nab         33 M 58 130 124 120 158 
Pradeep 25 M 50 128 122 124 150 
Kanag raj 45 M 54 132 130 132 148 
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Punithavathy               28    F 50 116 108 106 132 
Kathiravan              35 M 58 118 112 114 138 
Muniyappan 21 M 55 114 110 116 136 
Dinesh 35 M 60 108 104 112 122 
Gowri 24 F 50 112 112 118 122 
Senthil 42 M 58 124 122 124 152 
Sudha 38 F 50 126 120 124 144 
Sultan 26 M 50 128 122 128 148 
Mercy 41 F 48 130 126 132 155 
Muthu 44 M 54 132 128 130 152 
Boopathy 32 M 53 128 122 128 146 
Esther 48 F 56 110 104 112 134 
Vijayanand                 34 M 57 112 110 110 136 
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OPTIMAL TIME FOR INJECTION OF SMALL DOSE FENTANYL FOR 
BLUNTING THE CIRCULATORY RESPONSES TO TRACHEAL 
INTUBATION 
 
 
                                                          PROFORMA 
 
NAME:                                                     AGE/SEX:                           
WEIGHT: 
IP NO:                                               RANDOM NO: 
DIAGNOSIS:                            
SURGERY: 
 
PRE OP EVALUATION: 
 
          BP:                          CVS:                      Breath Holding Time: 
   PULSE:                            RS:                      
      Hb%: 
ASA Classification:                           MPC Class: 
 
STUDY GROUP: 
 
   GROUP I :     Inj Pentazocine 500µg / kg 5 mins before intubation  
   GROUP II:     Inj Fentanyl   2µg / kg  1  minute  before  intubation 
   GROUP III:    Inj Fentanyl  2µg / kg   5 minutes before intubation 
   GROUP IV:    Inj Fentanyl  2µg / kg 10 minutes before intubation 
 
INCLUSION CRITERIA: 
 
1)  ASA I & II patients 
2)  MPC I&II patients 
3)  Age 10 to 60 years 
 
EXCLUSION CRITERIA: 
 
1)  ASA III & IV patients 
2)  MPC CLASS III & IV patients 
3)  Age < 10 & >60 years 
4)  Obese Patients 
5)  Patients on cardiac drugs 
6)  Patients with HTN, DM, IHD, CRF 
7)  Intubation time > 15 secs 
 
PREMEDICATION: 
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     Tab Diazepam 10 mg PO; HS night before surgery 
     Tab Ranitidine 150 mg PO; 6 am on day of surgery 
 
 
INDUCTION: 
 
                 DRUG           DOSE            GIVEN 
Inj Thiopentone Sodium            5 mg / kg  
Inj Vecuronium Bromide         0.1 mg / kg      
Inj Fentanyl citrate            2 µg / kg  
Inj Pentazocine        500 µg / kg  
 
 
PARAMETERS: 
 
   VARIABLE         SAP 
   ( mm Hg ) 
        DAP 
    ( mm Hg 
) 
       MAP 
   ( mm Hg ) 
        HR 
  ( per min) 
Baseline 
 
    
Preintubation 
 
    
During           
Intubation 
    
1 Min After 
Intubation 
    
3 Mins After 
Intubation  
    
 
 
 SIDE EFFECTS: 
 
Hypertension MAP >130% of baseline value or  
>130 mmHg whichever is higher 
   YES / NO 
Hypotension MAP < 70% of baseline value  
or < 65mm Hg 
   YES / NO 
Tachycardia HR > 120 bpm 
 
   YES / NO 
Bradycardia HR <  60  bpm 
 
   YES / NO 
Dysrhythmia Any ventricular or supraventricular          
premature beat or rhythm other than sinus 
   YES / NO 
Skeletal muscle Chest tightness, tight bag and mask    YES / NO 
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rigidity ventilation 
Depression of 
spont. ventilation 
Fall in SPO2 to < 92% in room air before 
thiopentone injection 
   YES / NO 
Delayed 
recovery 
 
failure of the patient to wakeup even 20 to 
30 mins after the termination of 
anaesthesia 
   YES / NO 
Postoperative 
resp. depression 
fall in respiratory rate to < 12 and a fall in 
SPO2 value to < 92% in PACU 
   YES / NO 
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